Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic evaluation of time-dependent anti-factor Xa variability of therapeutic nadroparin in critically ill ICU patients
NL-OMON48502Active, not recruiting
- Sponsor
- Martini Ziekenhuis
- Start
- Aug 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of nadroparin in therapeutic anticoagulation, sponsored by Martini Ziekenhuis. Started Aug 2020; status: active, not recruiting.
02
Drugs
nadroparin
03
Conditions
therapeutic anticoagulation
Beyond the preview
Go deeper on NL-OMON48502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48502.